Skip to main content
Top
Published in: Dermatology and Therapy 7/2022

Open Access 23-06-2022 | Leg Ulcer | Original Research

Leg Ulcer Therapy by Local Injection of Autologous Growth Factors: Results of a Pilot Study

Authors: Petr Šíma, Valér Džupa, Adam Whitley, Spyridon Gkalpakiotis

Published in: Dermatology and Therapy | Issue 7/2022

Login to get access

Abstract

Introduction

Population ageing has led to an increase in the prevalence of many chronic diseases that occur in elderly patients including chronic wounds of various aetiologies, especially leg ulcers. The treatment of these wounds is lengthy and associated with health, economic and social problems. The aim of our study was to compare the outcomes of local injections of autologous growth factors with standard dressings for leg ulcer treatment.

Methods

The study included 25 patients with leg ulcers treated with autologous growth factors, and 15 patients treated with standard wet dressings only. The area and depth of ulcers were measured on days 0, 5, 28, 84 and 168, and statistically processed using the chi-square test, the Fischer exact test, the Wilcoxon two-sample test, the non-parametric paired Wilcoxon test and the Friedman analysis of variance (ANOVA) test at a significance level of 5%.

Results

Area and depth did not significantly differ between the two groups before initiation of the treatment (p = 0.472 and p = 0.242, respectively). During the study period, the average leg ulcer area decreased in both the study and control groups by 72% and 40%, respectively. The paired Wilcoxon test showed that this decrease was significant in the study group (p < 0.001), but not in the control group (p = 0.075).

Conclusion

Leg ulcers heal better when treated with autologous growth factor injections than when treated with standard dressings alone. A further study with a larger number of patients is needed to confirm the presented results. However, this method seems to be a promising way to treat ulcers of the lower extremities.
Literature
1.
go back to reference Afradi H, Saghaei Y, Kachoei ZA, Babaei V, Teimourian S. Treatment of 100 chronic thalassemic leg wound by plasma-rich platelets. Int J Dermatol. 2016;56:121–244. Afradi H, Saghaei Y, Kachoei ZA, Babaei V, Teimourian S. Treatment of 100 chronic thalassemic leg wound by plasma-rich platelets. Int J Dermatol. 2016;56:121–244.
2.
go back to reference Mohammadi MH, Molavi B, Mohammadi S, Nikbakht M, Mohammadi AM, Mostafaei S, Norooznezhad AH, Abdegah AG, Ghavamzadeh A. Evaluation of wound healing in diabetic foot ulcer using platelet-rich plasma gel: a single-arm clinical trial. Transfus Apher Sci. 2017;56:160–4.CrossRef Mohammadi MH, Molavi B, Mohammadi S, Nikbakht M, Mohammadi AM, Mostafaei S, Norooznezhad AH, Abdegah AG, Ghavamzadeh A. Evaluation of wound healing in diabetic foot ulcer using platelet-rich plasma gel: a single-arm clinical trial. Transfus Apher Sci. 2017;56:160–4.CrossRef
5.
go back to reference Sima P, Schurek J, Forostyak S, Dzupa V, Arenberger P. Management of leg ulcers using combined PRP therapy on nanofiber carrier: results of pilot study. Acta Chir Orthop Traumatol Cech. (In Press). Sima P, Schurek J, Forostyak S, Dzupa V, Arenberger P. Management of leg ulcers using combined PRP therapy on nanofiber carrier: results of pilot study. Acta Chir Orthop Traumatol Cech. (In Press).
6.
go back to reference Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016;387:1513–30. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016;387:1513–30.
7.
go back to reference Schurek J. [Expert report on the progress of work and achieved results for the entire period of the TACR project (TA02011402).] (In Czech) Praha, PrimeCell Therapeutics, 2013. Schurek J. [Expert report on the progress of work and achieved results for the entire period of the TACR project (TA02011402).] (In Czech) Praha, PrimeCell Therapeutics, 2013.
8.
go back to reference Tsai HC, Lehman CW. Chen CM use of platelet-rich plasma and platelet-derived patches to treat chronic wounds. J Wound Care. 2019;28:15–21.CrossRef Tsai HC, Lehman CW. Chen CM use of platelet-rich plasma and platelet-derived patches to treat chronic wounds. J Wound Care. 2019;28:15–21.CrossRef
10.
go back to reference Ahmed M, Reffat SA, Hassan A, Eskander F. Platelet-rich plasma for the treatment of clean diabetic foot ulcers. Ann Vasc Surg. 2017;38:206–11.CrossRef Ahmed M, Reffat SA, Hassan A, Eskander F. Platelet-rich plasma for the treatment of clean diabetic foot ulcers. Ann Vasc Surg. 2017;38:206–11.CrossRef
11.
go back to reference Piccin A, Di Pierro AM, Canzian L, Primerano M, Corvetta D, Negri G, Mazzoleni G, Gastl G, Steurer M, Gentilini I, Eisendle K, Fontanella F. Platelet gel: a new therapeutic tool with great potential. Blood Transfus. 2017;15:333–40.PubMedPubMedCentral Piccin A, Di Pierro AM, Canzian L, Primerano M, Corvetta D, Negri G, Mazzoleni G, Gastl G, Steurer M, Gentilini I, Eisendle K, Fontanella F. Platelet gel: a new therapeutic tool with great potential. Blood Transfus. 2017;15:333–40.PubMedPubMedCentral
14.
go back to reference Han G, Ceilley R. Chronic wound healing: a review of current management and treatments. Adv Ther. 2017;34:599–610.CrossRef Han G, Ceilley R. Chronic wound healing: a review of current management and treatments. Adv Ther. 2017;34:599–610.CrossRef
15.
go back to reference Semenic D, Cirman T, Rozman P, Smrke D. Regeneration of chronic wounds with allogenic platelet gel versus hydrogel treatment: a prospective study. Acta Clin Croat. 2018;57:434–42.PubMedPubMedCentral Semenic D, Cirman T, Rozman P, Smrke D. Regeneration of chronic wounds with allogenic platelet gel versus hydrogel treatment: a prospective study. Acta Clin Croat. 2018;57:434–42.PubMedPubMedCentral
16.
go back to reference Bishop SM, Walker M, Rogers AA, Chen WY. Importance of moisture balance at the wound-dressing interface. J Wound Care. 2003;12:125–8.CrossRef Bishop SM, Walker M, Rogers AA, Chen WY. Importance of moisture balance at the wound-dressing interface. J Wound Care. 2003;12:125–8.CrossRef
17.
go back to reference Xia Y, Zhao J, Xie J, Lv Y, Cao DS. The efficacy of platelet-rich plasma dressing for chronic nonhealing ulcers: a meta-analysis of 15 randomized controlled trials. Plastic Reconstr Surg. 2019;144:1463–74.CrossRef Xia Y, Zhao J, Xie J, Lv Y, Cao DS. The efficacy of platelet-rich plasma dressing for chronic nonhealing ulcers: a meta-analysis of 15 randomized controlled trials. Plastic Reconstr Surg. 2019;144:1463–74.CrossRef
19.
go back to reference Babaei V, Afradi H, Gohardani HZ, Nasseri F, Azarafza M, Teimourian S. Management of chronic diabetic foot ulcers using platelet-rich plasma. J Wound Care. 2017;26:784–7.CrossRef Babaei V, Afradi H, Gohardani HZ, Nasseri F, Azarafza M, Teimourian S. Management of chronic diabetic foot ulcers using platelet-rich plasma. J Wound Care. 2017;26:784–7.CrossRef
20.
go back to reference Feng G, Hao DF, Yao D, Zhang XJ, Yang Y. [Clinical effects of autologous platelet-rich plasma gel in the repair of chronic wounds.] (In Chinese) Zhonghua Shao Shang Za Zhi. 2019; 35:451–5. Feng G, Hao DF, Yao D, Zhang XJ, Yang Y. [Clinical effects of autologous platelet-rich plasma gel in the repair of chronic wounds.] (In Chinese) Zhonghua Shao Shang Za Zhi. 2019; 35:451–5.
Metadata
Title
Leg Ulcer Therapy by Local Injection of Autologous Growth Factors: Results of a Pilot Study
Authors
Petr Šíma
Valér Džupa
Adam Whitley
Spyridon Gkalpakiotis
Publication date
23-06-2022
Publisher
Springer Healthcare
Published in
Dermatology and Therapy / Issue 7/2022
Print ISSN: 2193-8210
Electronic ISSN: 2190-9172
DOI
https://doi.org/10.1007/s13555-022-00753-7

Other articles of this Issue 7/2022

Dermatology and Therapy 7/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.